chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt received first dose on 2/27/21 but had reported to the ward staff that first dose was given "around the 17th".  First dose date was not verified until the second dose was given on 3/10/21.  Second dose was given 10 days early in error.
20 mins after injection felt dizzy and face numbness. 12 hours after injection felt nausea, chills, fever, fatigue. Fatigue persisted for 36 hours. 48 hours after injection, face numbness returned and persisted for about 3 hours. Localization around the eyes and nose.
Elevated BP highest was 180s/110s. Began the night she received the vaccine and resolved after 7 days with the help of her physician. Recovering from breast cancer and on chemo.
PT RECEIVED 0.2ML OF THE PURPLE CAP FORMULATION  INSTEAD OF ORANGE CAP. NO REPORTABLE SIDE EFFECTS BY MOTHER IN EVENING
0.5ml was administered to the patient instead of recommended 0.25ml. Spoke with dad the next day and patient is doing fine, a little under the weather but doing fine per dad
Extreme fatigue,  swollen right eye, redness and pain in right eye, low grade fever.  Malaise and excessive sleeping
Hot to cold, headache, fatigue, cough, chest pain, boughts of breathlessness this was day 2, day 3 headache, body ache, chest pain probably from coughing. Cough was deep and hard in the morning after waking  through out the morning I would cough a couple more time by noon I'm not coughing but my chest is heavy.
Immediately after vaccination patient climbed off the exam table, laid herself down on the floor and then had 2-3 seconds of the left side of her body jerking-including her head tilting to the left side. Her eyes rolled back at onset and her lips appeared blue and she appeared unresponsive during the short episode. When the jerking stopped she immediately became responsive and alert and color returned.
Patient became clammy and felt light-headed..had to sit down.  We called 911 to come check him out, but the patient insisted he was starting to feel better.  Vital signs all checked out ok.
fatigue; fever; Caller is a pharmacist who is reporting administration of undiluted doses of the Pfizer-Biontech Covid19 vaccine to 4 total patients; Caller is a pharmacist who is reporting administration of undiluted doses of the Pfizer-Biontech Covid19 vaccine to 4 total patients; This is a spontaneous report from a Pfizer sponsored program (RA). A contactable pharmacist reported for a 22-year-old female patient that: A 22-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: EW0180; Expiration Date: 31Aug2021), via an Intramuscular route of administration in right deltoid on 02Jul2021 at 09:00 (at the age of 22-year-old) as dose 2, 0.3 ml single for COVID-19 immunisation in pharmacy. The patient medical history and concomitant medications were not reported. The patient's medical history (including any illness at time of vaccination) was unknown. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: Unknown; Expiration Date: Unknown), via an unspecified route of administration on an unknown date (at the age of 22-year-old) as dose 1, single for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Additional vaccines administered on same date of the Pfizer suspect was unknown. Adverse events following prior vaccinations was unknown. The reporter was a pharmacist reporting higher than the recommended dose of the Pfizer COVID 19 vaccine. On 02Jul2021 (before 10:00), the product was not diluted before being given and was given to 4 patients. Did not confirm whether these were first or second doses. The reporter was asked if this has been studied before and what adverse events to anticipate. The reporter stated that she does not have all of the information, as she was not the one that administered the vaccines. She could forward it on to whoever needs to get it, as far as that goes. Upon follow-up on 09Aug2021, Reporter stated that Patient experienced Fatigue and Fever on 02Jul2021 at 12:00. The adverse event did not result in a visit to emergency room and physician office. AE resolved with the use of Tylenol /Advil. The events were reported as non-serious. The outcome of the events Fatigue and Fever was recovered on an unspecified date on 2021.  Follow-up attempts are completed. No further information is expected.   Follow-up (09Aug2021): This is a follow-up spontaneous report from a contactable pharmacist. This pharmacist reported for a female patient in response to HCP letter via follow-up letter which included that: vaccination time and route of administration was updated. New event added.   Follow-up (18Aug2021): Follow-up attempts are completed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021830001 same reporter/drug/AE with different patient
Left arm red, swollen and warm to the touch 2 days after immunization given. Treated w. BACTIM and completely resolved within 2-3 days of starting antibiotic.
I had soreness at the injection site for a couple of days. I began not feeling well on 12/27/2022 with sneezing and coughing. I thought my allergies were acting up. On 01/01/2023 I tested positive with a home test for COVID-19. I was out of state when I tested positive for COVID-19 and contacted my doctor's office over the phone. I got a prescription for Paxlovid five hours later. I started feeling better, but it all returned with a vengeance.  I started taking over the counter medication to relieve my symptoms. I was sick for 19 days.  As of today, I still have a cough.
Awoke with rubbery legs, urinary incontinence, fell 19 days post vax. At ER, cath inserted, release. Next day, admitted to hosp. Treated improved. Neuropathy persists, pt continues to use hand walker, incontinence of urine persists. Diag with GBS.
At the 10 minute mark patient reported not feeling well. She was noted to be pale. Then she reported having slight breathing problems along with her heart racing. Call for ER staff to report to vaccinating area. Patient's breathing concern resolved on its own by the time ER response team arrived within 2 minutes. Patient slowly gained her color back. Heart palpitations lessening but still reported by patient. Blood pressure / O2 Saturations / Respiratory rate monitored. No oxygen or treatment required at this time. Patient taken upstairs to be monitored by ER staff.
No adverse event; got vaccinated after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD) and NO ADVERSE EVENT (No adverse event) in a 57-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 03-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 03-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD).    No concomitant medication were reported. No treatment information was provided by the reporter.The patient got vaccinated after BUD.
102 fever, chills - started 12 hours after shot, lasted about 36 hours muscle aches, backache, headache - started 10 hours after shot, still experiencing 48 hours later
DATE OF ADMISSION:  10/14/2022   DATE OF DISCHARGE:  10/18/2022     DISCHARGE DIAGNOSIS: 1. Cough, shortness of breath due to COVID and chronic obstructive pulmonary disease exacerbation.  2. Pseudoseizures and history of seizure disorder.  EEG was unremarkable.  3. Diabetes mellitus, insulin dependent with uncontrolled blood sugars due to steroids.  4. Acute kidney injury with history of chronic kidney disease, stage 3.  5. Morbid obesity, obstructive sleep apnea.  Does not use CPAP.  6. History of deep venous thrombosis, pulmonary embolism, on Eliquis.  7. Cerebral palsy.  8. Chronic low back pain.  9. Human immunodeficiency virus, on medications.  10. Anxiety and depression.  11. Coronary artery disease with his history of cardiac cath and stenting.
After receiving immunizations the patient ate lunch and took a 1/2 hour nap. Awoke suddenly screaming terriby-lasted 15 minutes, calmed down eventually on own and acted fine.  Since then, bouncing back & forth between extremes lasting 1-10 minutes-inconsolable.  No seizure activity. When he calms down, he stares off into space for about 5 minutes, unresponsive to redirections.
allergic reaction; Initial information regarding an unsolicited valid non-serious case was received from a pharmacist via Medical Information (Reference number- 00542982) and transmitted to Sanofi on 31-Mar-2021.  This case involves a 66 years old patient (age unspecified) who had an allergic reaction (hypersensitivity) when received INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QIV].  Medical history, medical treatment(s), vaccination(s), concomitant medications and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (lot ZUH201AA, expiry date: 30-Jun-2011) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date the patient developed a non-serious allergic reaction (hypersensitivity) (unknown latency) following the administration of INFLUENZA QUADRIVAL A-B VACCINE.  The caller (pharmacist) was requesting a product composition list for Fluzone Quadrivalent from year 2010. The patient reported that she had an allergic reaction after receiving the Fluzone vaccine. The caller has a patient who is interested in getting the coronavirus disease (COVID 19) vaccine. The caller would like to compare the list of ingredients from 2010 Fluzone Quadrivalent to the COVID 19.   No laboratory data was provided  It was not reported if the patient received a corrective treatment for the event  At time of reporting, the outcome of event was unknown.
6 days after patient received influenza vaccine patient was sick; Initial information regarding an unsolicited valid non-serious case was received from a consumer (patient) via social media and transmitted to Sanofi on 22-Oct-2020.  This case is linked to case 2020SA300039.  This case involves a patient of an unknown age for whom it was reported that six days after the patient received influenza vaccine, the patient was sick (illness).  Medical history, medical treatments, vaccinations, concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) (lot number unknown) via an unknown route in an unknown administration site for prophylactic vaccination.  On an unknown date, six days after the patient received influenza vaccine, the patient was sick (illness).  Final diagnosis was illness.  No relevant laboratory tests were reported.  It was not reported if the patient received a corrective treatment.  Event outcome was reported as unknown for illness.  There will be no information regarding the batch number for the case.
The pt experienced injection site reaction and fatigue, abdominal muscular pain, pain at site, dizziness, fever, nausea, weakness and achy.
2 episodes of seizures; This spontaneous case was reported by a consumer and describes the occurrence of SEIZURE (2 episodes of seizures) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066D21A) for COVID-19 vaccination.     Concurrent medical conditions included Epilepsy (on the seizure medication and not had any seizure since last 23 years until 22Aug2021.).    On 18-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Aug-2021, the patient experienced SEIZURE (2 episodes of seizures) (seriousness criteria hospitalization and medically significant). At the time of the report, SEIZURE (2 episodes of seizures) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient was on  seizure medication for Epilepsy.  On 22Aug2021, Caller experienced 2 episodes of seizures for which he had to go the emergency room. Caller mentioned that he had been on the seizure medication for Epilepsy. Caller believed that vaccine must have potentially triggered the seizure since he had not had any seizure since last 23 years until 22Aug2021.  Company Comment: This case concerns a 50-year-old, male subject with a history of epilepsy, who experienced the unexpected event of seizure. The event occurred 4-days after the first dose of Moderna covid-19 vaccine. The rechallenge is unknown for this case. The event was not provided as per the reporter's assessment. The medical history of epilepsy remains a confounder.The benefit-risk relationship of the vaccine is not affected by this report; Sender's Comments: This case concerns a 50-year-old, male subject with a history of epilepsy, who experienced the unexpected event of seizure. The event occurred 4-days after the first dose of Moderna covid-19 vaccine. The rechallenge is unknown for this case. The event was not provided as per the reporter's assessment. The medical history of epilepsy remains a confounder.The benefit-risk relationship of the vaccine is not affected by this report
Tdap vaccine administered Monday 4-13-14. Soreness started Wednesday in left upper arm, radiates to left shoulder and neck area. Instructed to take TYLENOL warm compress to neck area.
My daughter was meeting a few of her milestones like rolling over, holding her head, swatting at toys and her eye track was great. The day of the vaccines I told her pediatrician she had a cold and to hold off on thee vaccines. She had goopy eyes and sniffles. The doctor said the vaccine would not affect her at all so we went ahead and got her the vaccines. Trusting my pediatrician knew what she was doing. My daughter at the time was 19 lbs she is now almost 4 and we struggle to keep her at 26lbs. The day of the vaccine she began shaking at night so I took her to the ER and was told she had a seizure. I have records of all this. She stopped moving her limbs, did not track and was basically in a vegetative state. She lost weight so I took her to many specialists after.
Two hours after vaccination, patient had wheezing, difficulty breathing and red eyes. He was not able to sleep during the night. Symptoms resolved at 2 PM next day. No doctor consulted by patient.
This spontaneous report was received from a registered nurse referring to some patients of unknown age and gender, that were vaccinated, on an unknown date, with a dose of RECOMBIVAX HB, (dose, route of administration and lot # not reported). Information regarding concomitant therapy, concurrent conditions and medical history was not provided. The nurse reported that the RECOMBIVAX HB was administered to patients post supported excursion. No adverse effects noted by any patient. This is one of several reports from the same reporter source. Additional information has been requested.
pt recv vax late 1998 or early 1999 & devel influenza in 1/99;hlth dept told MD that an H3N2 strain was circulating in are;exact strain not provided;
Redness and itching a week after injection on the right arm. Redness area is approximately 4 in in length and 3 in in width
Narrative:  Patient developed itchy rash on arms and legs at zoster vaccine. Refuses second dose.
Describe the adverse event(s), treatment, and outcome(s), if any: (symptoms, signs, time course, etc.)   lump in my throat; turned red on my face and neck and chest and arms; when I get nervous; between my eyes on my forehead felt like a round circle (no bump) (past the bridge above eyebrows). It didn't hurt, but I felt something; felt odd; felt like my eyes were moving back and forth; very very cold; hands were ice cold; This is a spontaneous report received a contactable consumer, the patient. A 60-year-old adult female received the first dose BNT162b2 (solution for injection; batch/lot and expiry information not reported) as a single dose via unspecified route on 14Mar2021 (at 60-years-old), for COVID-19 immunisation. Relevant medical history included high blood pressure, and diabetes. There were no concomitant medications or past drug history reported. The patient reported that she had a couple of reactions the first day, so she was afraid to take the second one. The patient stated that within eight minutes she had a lump in her throat, which she gets when she is nervous and was unsure if from shot or nervousness. The patient reported that then she turned red on her face, neck, chest, and arms. The patient reported that the redness lasted about six or seven hours and did not bother her at all. The patient explained that then between her eyes on her forehead felt like a round circle (no bump) past the bridge above eyebrows. The patient stated that it did not hurt but felt like something. The patient also stated that she felt like she was going to get headache, though did not. The patient reported that it just felt odd. The patient also stated that she felt like her eyes were moving back and forth. Though when she looked in the mirror, they were fine. The patient stated that the eyes happened three times but by the time she looked in the mirror they looked fine. The patient added that she never felt sick or anything though about six or eight hours later she got very very cold which only lasted about a minute. The patient stated that her hands were ice cold and then it all went back to normal. The outcome of the events turned red on my face and neck and chest and arms was recovered on an unspecified date in Mar2021 after 6-7 hours. The outcome of the event she got very very cold was recovered on an unspecified date in Mar2021 after one minute. The outcome of the events hands were ice cold, and felt like my eyes were moving back and forth was recovered on an unspecified date in Mar2021. The outcome of the events, lump in my throat, get nervous, between my eyes on my forehead felt like a round circle (no bump), felt something, and felt odd, was unknown.  Information on lot/batch number has been requested. Follow-up attempts are completed. No further information is expected.
After receiving FLUVIRIN multidose within two hours severe nausea set in. Within ten minutes of receiving the vaccine my arm felt extremely hot. Both issues have not subsided as of 9/23/17.
Received a Moderna booster shot but she needed a second dose of the Pfizer COVID 19 vaccine; Received a Moderna booster shot but she needed a second dose of the Pfizer COVID 19 vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received a Moderna booster shot but she needed a second dose of the Pfizer COVID 19 vaccine) and WRONG PRODUCT ADMINISTERED (Received a Moderna booster shot but she needed a second dose of the Pfizer COVID 19 vaccine) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for COVID-19 vaccination: Pfizer COVID 19 vaccine (Dose: 1). Past adverse reactions to the above products included No adverse event with Pfizer COVID 19 vaccine.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received a Moderna booster shot but she needed a second dose of the Pfizer COVID 19 vaccine) and WRONG PRODUCT ADMINISTERED (Received a Moderna booster shot but she needed a second dose of the Pfizer COVID 19 vaccine). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received a Moderna booster shot but she needed a second dose of the Pfizer COVID 19 vaccine) and WRONG PRODUCT ADMINISTERED (Received a Moderna booster shot but she needed a second dose of the Pfizer COVID 19 vaccine) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No medical history information was reported.  Concomitant medication of the patient was not reported.  The patient stated she already had two Pfizer shots and needed a booster. As, the patient needed booster dose of a COVID-19 vaccine, Moderna COVID-19 vaccine was administered (half the dose as it was a booster). It was later found out actually she needed a second dose of the Pfizer COVID 19 vaccine. The patient did not have her vaccination card at the time of vaccination.  No treatment information was provided by the reporter.   Reporter did not allow further contact
This spontaneous report as received from a medical student, refers to an unspecified children patients of unknown age and gender. No information on patients' concurrent conditions, medical history and concomitant therapies was reported. On an unknown dates, the children patients were vaccinated with M-M-R II (dose, route, lot # and expiration date were not reported) and with other unspecified vaccines. The reporter stated that he had read many different unspecified articles and books and watched a movie, which were telling that M-M-R II and other unspecified vaccines were causing autism in children. The outcome of autism was unknown. Upon internal review, the autism was determined to be medically significant. Additional information has been requested.
tingling; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling) and FATIGUE (fatigue) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced PARAESTHESIA (tingling) and FATIGUE (fatigue). At the time of the report, PARAESTHESIA (tingling) and FATIGUE (fatigue) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.    This case was linked to MOD-2021-063868 (Patient Link).
patient presents to ED with COVID symptoms and positive test. Treated with Regeneron antibodies. Fully vaccinated in May 2021.
Fever within 24 hrs (102), resolved within 48 hrs.  Malaise, myalgias, improving within 48 hrs.
pt recvd vax; a few hrs p/ vax, became lethargic w/ T 101-102; to MD who stated not to cont DTP;pt ill for 2 wks;resistance was lower & pt devel cold
Loose stools, numbness in hands & legs, nausea, weakness, lightheaded Naproxen every 4 hours per Dr.